Galen Management, LLC

CIK 1421162 · last filed 2017-09-19

Galen Management, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider sold $346.7M of TCMD on Sep 19, 2017. Across all open-market trades the lifetime net is −$378.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.49M

Companies

2

Total Filings

5

Lifetime Open-Market Net

-$378.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCMD 10%+ Owner 907,736 $30.28 $27.49M -$378.60M 4 2017-09-19
ACURA PHARMACEUTICALS, INC (ACUR) Delisted 10%+ Owner 11,784,527 -$236.4K 1 2013-06-11

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-09-19 TCMD Sell (S) −11,178,000 -$346.74M EDGAR
2017-06-29 TCMD Sell (S) −800,000 -$23.08M EDGAR
2017-06-22 TCMD Sell (S) −332,000 -$8.78M EDGAR
2016-08-04 TCMD Conv (C) +18,974,532 $0 EDGAR
2013-06-11 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −107,480 -$236.4K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.